Antimalarial therapies.
Analysis of the trends in antimalarial research depicts a slow growth in launched products since 1995. However, 2002 saw the completion, after ten years, of the malarial genome project and an upsurge in products entering active development can be seen at the end of this period.
Trafford
Hugh
H
Pharmaprojects, PJB Publications, 69-77 Paul Street, London, EC2A 4LQ, UK. hugh.trafford@informa.com
D000962:Antimalarials / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003906:Developing Countries; D018432:Drug Resistance, Multiple; D006801:Humans; D017780:Malaria Vaccines; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000517:prevention & control
D000962:Antimalarials; D017780:Malaria Vaccines